Chemoradiotherapy Improved Survival in Older Patients With Stage 2 NSCLC

Chemoradiotherapy (CRT) was preferred to radiotherapy alone in patients older than 65 years who had stage II nonsurgical non–small cell lung cancer (NSCLC), as overall survival (OS) and cancer-specific survival (CSS) were both improved in…